These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 28482586)
1. Biodegradable poly(D,L-lactide-co-glycolide)/poly(L-γ-glutamic acid) nanoparticles conjugated to folic acid for targeted delivery of doxorubicin. Jaimes-Aguirre L; Morales-Avila E; Ocampo-García BE; Medina LA; López-Téllez G; Gibbens-Bandala BV; Izquierdo-Sánchez V Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():743-751. PubMed ID: 28482586 [TBL] [Abstract][Full Text] [Related]
2. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug. Kuo YC; Yu HW Colloids Surf B Biointerfaces; 2011 Nov; 88(1):158-64. PubMed ID: 21764569 [TBL] [Abstract][Full Text] [Related]
3. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
4. Construction of nanoparticles based on amphiphilic copolymers of poly(γ-glutamic acid co-L-lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine as a potential drug delivery carrier. Liu X; Su S; Wei F; Rong X; Yang Z; Liu J; Li M; Wu Y J Colloid Interface Sci; 2014 Jan; 413():54-64. PubMed ID: 24183430 [TBL] [Abstract][Full Text] [Related]
5. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy. Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518 [TBL] [Abstract][Full Text] [Related]
6. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery. Xin Y; Liu T; Yang C Int J Nanomedicine; 2016; 11():5807-5821. PubMed ID: 27853366 [TBL] [Abstract][Full Text] [Related]
7. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles. Kuo YC; Chen YC Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991 [TBL] [Abstract][Full Text] [Related]
9. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery. Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060 [TBL] [Abstract][Full Text] [Related]
10. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release]. Li JL; Zheng CL; Liu JP; Zhu JB Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702 [TBL] [Abstract][Full Text] [Related]
11. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles. Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911 [TBL] [Abstract][Full Text] [Related]
12. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity. Zhang C; Zhang Z; Zhao L Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055 [TBL] [Abstract][Full Text] [Related]
13. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity. Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812 [TBL] [Abstract][Full Text] [Related]
14. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777 [TBL] [Abstract][Full Text] [Related]
15. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies. Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818 [TBL] [Abstract][Full Text] [Related]
16. [Polyelectrolyte layer-by-layer assembled lipid nanoparticles for improving oral absorption of doxorubicin]. Shen AJ; Xia DN; Gan Y; Li J Yao Xue Xue Bao; 2016 Jul; 51(7):1136-43. PubMed ID: 29897223 [TBL] [Abstract][Full Text] [Related]
17. Multi-functional core-shell Fe S R; M P Colloids Surf B Biointerfaces; 2019 Feb; 174():252-259. PubMed ID: 30469046 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system. Amjadi I; Rabiee M; Hosseini MS; Mozafari M Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, physicochemical characterization, and in vitro evaluation of biodegradable PLGA nanoparticles entrapped to folic acid for targeted delivery of kaempferitrin. Govindarasu M; Abirami P; Alharthi SS; Thiruvengadam M; Rajakumar G; Vaiyapuri M Biotechnol Appl Biochem; 2022 Dec; 69(6):2387-2398. PubMed ID: 35020231 [TBL] [Abstract][Full Text] [Related]
20. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells. Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]